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Abstract
Background: With improving surgical techniques for total elbow arthroplasty clinical outcomes have improved and
its utilization continues to increase. Despite these advances, complication rates remain as high as 24%. Of these
complications periprosthetic joint infection is one of the most common and morbid. The rheumatoid elbow
remains a leading indication for total elbow arthroplasty. Patients with this condition frequently require
immunosuppressive therapy, which places them at higher risk of both typical and atypical infections.
Case presentation: We present the case of a persistent, late-onset periprosthetic joint infection in a total elbow
arthroplasty of a 64-year-old Caucasian woman with severe refractory rheumatoid arthritis. The offending pathogen,
Aspergillus terreus, is previously unreported in the arthroplasty literature and grew concurrently with coagulase-
negative staphylococcus. Eradication of the fungal and bacterial agents involved resection arthroplasty, serial
debridement, and multiple courses of intravenous and oral antimicrobial therapy. Two attempts at reimplantation
arthroplasty failed to eliminate the infection and our patient ultimately required definitive resection arthroplasty.
Conclusions: Arthroplasty in the rheumatoid elbow confers with it a high complication rate. Inflammatory disease
and immunosuppressive drugs combined with the subcutaneous anatomy of the elbow contribute to the risk of
infection. Fungal periprosthetic joint infection in the rheumatoid patient presents both diagnostic and therapeutic
challenges. Fungal growth should always be treated and requires organism-specific antimicrobials in conjunction
with surgical debridement. More literature is needed to determine the optimal treatment regimen for this
devastating complication.
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Background
With improvements in outcomes of total elbow arthro-
plasty (TEA) [1], the procedure has become increasingly
more common. Rates of TEA utilization in the United
States doubled over a 14-year period to a rate of 0.96
per 100,000 [2]. Despite advances in technique and hard-
ware components, complication rates remain high in
comparison to other joint arthroplasties. A systematic
review of the literature from 1992 to 2009 estimated that
the significant complication rate was as high as 24.3%
[1]. Of these complications, periprosthetic joint
infections (PJI) are one of the more common and most
devastating, and have been estimated to occur in 5–8%
of patients [3]. The treatment of PJI is well described in
arthroplasty literature and carries with it significant
morbidity. However, the literature on PJI in TEA is still
limited and, to the best of our knowledge, there are no
published reports of fungal infection following TEA. The
existing literature concerning fungal PJI of the other
joints mostly consists of case series and consensus state-
ments. Here we present the complex case of persistent,
late-onset Aspergillosis of a total elbow arthroplasty in a
patient with severe refractory rheumatoid arthritis.
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Case presentation
A right-handed, 64-year-old Caucasian woman presented
for reimplantation left TEA. She had had a left total
elbow resection arthroplasty in April 2014 due to a fun-
gal PJI. Her past medical history was significant for a 41-
year history of severe refractory rheumatoid arthritis in-
volving multiple joints and cervical spine. She had failed
multiple medical therapies including disease-modifying
antirheumatic drugs and biologics, and was treated
intermittently with prednisone for flares.
The original DePuy Pritchard TEA (DePuy, Warsaw,
IN, United States) was implanted in 1995. It had per-
formed well until June 2007 when she developed left
elbow pain and fevers and received a liner exchange in
well-fixed implants (Fig. 1). The TEA was retained until
she required resection arthroplasty in July 2011 after re-
peat debridement and antimicrobial regimens failed to
resolve a draining sinus due to a coagulase-negative
staphylococcus (CONS) infection. The implant was re-
placed with a vancomycin-impregnated cement spacer.
Intraoperative cultures grew CONS for which she was
treated with cefazolin for 8 weeks. Two months postop-
eratively the spacer was removed but tissue cultures
remained positive for polymicrobial infection including
CONS and Enterobacter cloacae. Extended antimicro-
bials consisted of 6 weeks of ciprofloxacin and vanco-
mycin. In December of 2011 reimplantation was
attempted but abandoned when intraoperative frozen
sections showed >30 white blood cells per high-powered
field (WBC/hpf ). Definitive tissue cultures grew new
Aspergillus terreus only, which was thought to be a con-
taminant after growing on only one of six fungal
cultures.
In February 2012, she was off of all immunosuppres-
sives and systemically well. The elbow was healed and
free of any drainage. Her C-reactive protein (CRP) level
was 8.7 mg/L and erythrocyte sedimentation rate (ESR)
was 29. Reimplantation surgery was undertaken using a
similar method reported by LeBlanc et al. 2012 [4]; an
allograft-prosthetic composite was used consisting of a
long-stemmed cemented Coonrad-Morrey TEA (Zim-
mer) and tibial allograft on the humeral side (Fig. 2). In-
traoperatively there was no concern for infection, but
final cultures grew scant CONS and Aspergillus terreus
and histologic samples were nonspecific. She was treated
as a mixed fungal and bacterial PJI and treated with
8 weeks of intravenous voriconazole and vancomycin.
The implant was retained.
In the following 6 months she healed and was doing
well until a rheumatoid flare. She was put on a trial of
abatacept and shortly after developed a fluctuant mass
around the lateral distal humerus. An aspiration of the
collection grew Aspergillus terreus and the abatacept was
stopped. Blood work showed a CRP level of 10.4 and an
ESR of 50. Over the course of the next 7 months, she
would undergo eight more serial aspirates of the recur-
rent collection with only the first specimen growing As-
pergillus terreus. A bone scan showed no increased
uptake, but repeat radiographs showed the presence of
an insufficiency fracture on the ulnar side (Fig. 3).
Fig. 1 Left total elbow arthroplasty showing well-fixed components
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Fig. 2 Left revision total elbow arthroplasty with cemented allograft prosthetic composite
Fig. 3 Revision total elbow arthroplasty with new ulnar-sided insufficiency fracture
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During this time she remained off of antimicrobial treat-
ment in an attempt to identify the offending organism.
With failure to control Aspergillosis of the left TEA
with combined serial (two) operative debridements and
medical management, a second resection arthroplasty
was performed in April 2014. Aspergillus terreus grew
on one of three cultures but no bacterial growth was
identified. Postoperative antimicrobial therapy consisted
of caspofungin and cefazolin for 8 weeks, followed by
cephalexin and a short trial of oral voriconazole, which
was stopped due to gastrointestinal intolerance and
transaminitis.
Eleven months post left TEA resection arthroplasty for
chronic Aspergillosis, she was systemically well and had
been off of antimicrobials for 5 months. A physical
examination revealed a left flail elbow, she was neuro-
logically intact with good function of the hand and a
well-healed posteriorly based scar. There were no signs
of infection or inflammation. Her most recent laboratory
test results showed a WBC count of 6.2 × 10E9/L, a
CRP level of 2.2 mg/L and an ESR of 25, all within nor-
mal limits. The last positive tissue culture was from the
resection arthroplasty in April 2014 and no further spec-
imens had been collected. Plain radiographs showed a
significant osseous defect of the proximal ulna and distal
humerus (Fig. 4). A bone scan and white blood cell scan
showed no definitive evidence of ongoing infection.
In March 2015, after consultation with infectious dis-
eases and local orthopedic colleagues, our patient and
surgeons elected to proceed with a second attempt at
reimplantation arthroplasty. Due to extensive bone loss,
the reimplantation was performed using a cemented dis-
tal humerus endoprosthesis and long-stemmed ulna
component (Biomet SRS/Discovery TEA; Zimmer Bio-
met) (Figs. 5 and 6). Multiple tissue specimens collected
intraoperatively were negative for fungal and bacterial
growth.
Unfortunately, after a brief symptom-free period she
developed a recurrent sinus over the tip of the olecranon
and recurrent CONS was confirmed. Our patient has
since undergone definitive resection arthroplasty. No
further fungal infection was identified and no further
surgery is planned.
Discussion
Fungal infection in elbow arthroplasty
Only 1% of PJIs are of fungal origin [5], and because of
this rarity, the literature is limited to a few small case
series and consensus statements mostly based on hip
and knee arthroplasty. Since relatively few TEAs are per-
formed compared to hip and knee arthroplasties, the in-
cidence of fungal PJI in TEA is unknown [6]. The most
common organisms in fungal PJI are Candida species
[7]. Aspergillus fumigatus and Aspergillus niger have also
Fig. 4 Left elbow resection arthroplasty
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been reported in the arthroplasty literature in small
numbers [8] but, to the best of our knowledge, there
have been none for Aspergillus terreus.
Many patients requiring TEA have pre-existing
rheumatoid arthritis (RA). It has been proposed that the
high complication rate of TEA in patients with RA could
be attributed to a combination of poor bone stock, min-
imal posterior soft tissue coverage, and immunodefi-
ciency [9]. In RA, either the pathologic process itself
causes the immunodeficiency, or the pharmacology used
to treat it [10]. Like in our case, many of these patients
will be at higher risk of atypical infections, which can
potentially lead to catastrophic morbidity
Diagnosis of fungal infection in elbow arthroplasty
Fungal PJIs are often hard to diagnose and can be com-
plicated by comorbidities and concurrent or previous
bacterial infection [10]. Regardless, diagnosis begins with
a thorough history and physical examination similar to
any presentation of PJI. Diagnostic imaging including
plain radiographs should always be obtained, but ad-
vanced three-dimensional imaging and nuclear medicine
tests have not been recommended for routine use in the
diagnosis of PJIs [11]. Serologic markers are unable to
distinguish between causative organisms and synovial
fluid rarely identifies fungal pathogens [10]. As a result
of this, special attention must be given to specimen
collection, as routine cultures may show no growth in
the setting of a high clinical suggestion. To improve
diagnostic yield, serial joint aspirations and multiple in-
traoperative specimens from diagnostic or therapeutic
procedures are essential to help establish the causative
organism [12, 13]. Fungal cultures should be plated on
fungal selective media (for example, Sabourad dextrose)
and growth can take up to 4 weeks [5]. When cultures
do yield fungal organisms, results are still often misinter-
preted. In a 2013 systematic review of fungal PJIs,
Kuiper et al. found that fungal growth was initially
Fig. 5 Left revision total elbow arthroplasty anteroposterior view
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considered contamination in 21% of cases. They con-
cluded that any fungal species grown should thus be
considered a pathogen [7].
In this case, the underlying RA and history of bacterial
PJI in the same joint complicated the diagnosis. Sero-
logic markers including ESR and CRP were difficult to
interpret in the context of severe RA. The previous and
intermittent presence of CONS from aspirates and surgi-
cal specimens not only confounded organism-specific
therapy but also significantly increased the patient’s
baseline risk for a fungal PJI [12]. Initial suggestion of
Aspergillus spp. as a contaminant may have led to de-
layed time to antifungal treatment and premature
second-stage reimplantation with the first revision. In
retrospect, a histologic evaluation of WBC/hpf at the
time of reimplantation in February 2012 may have de-
tected continued inflammation and reconsideration of
the Aspergillus spp. as a contaminant. However, while
frozen histologic section has been shown to be highly
specific at 93.1%, it is only 51.3% sensitive [14]. Add-
itionally, its utility in both fungal infections and patients
with underlying arthropathies is still poorly defined [15].
Eradication of fungal infection in elbow arthroplasty
Fungal PJIs are not only difficult to diagnose but are also
thought to be challenging to treat. Standardized proto-
cols for the treatment of PJI have been produced by the
Infectious Diseases Society of America (IDSA) but have
not been customized for fungal PJI, let alone fungal PJI
in TEA. The optimal treatment of PJI consists of both
medical and surgical intervention [3, 11, 12].
Medical management includes systemic antifungals
prior to reimplantation, and debate still exists surround-
ing the use of antifungal-impregnated spacers owing to a
lack of evidence [12]. The IDSA currently recommends
between 4 and 6 weeks of organism-specific intravenous
or highly bioavailable oral antimicrobial therapy follow-
ing resection arthroplasty, but does not distinguish be-
tween bacterial and fungal organisms. As was seen in
this case, prolonged use of antifungals raises the risk of
systemic toxicity and poses a challenge when considering
length of therapy [5]. Cheung et al. used a similar anti-
microbial treatment regimen in their experience of 29
bacterial PJIs of TEAs. Medical management in two-
stage revisions included tobramycin/vancomycin-im-
pregnated cement spacers and 6 weeks of organism-
specific intravenous antibiotics. None of their causative
organisms were fungal [16].
Surgical options include resection arthroplasty, one-
and two-staged revision, arthrodesis, and amputation. A
2015 systematic review of 45 fungal infections in total
knee arthroplasty recommended a two-staged approach
as the gold standard. This consisted of resection arthro-
plasty with or without antibiotic-impregnated cement
spacers, followed by delayed reimplantation. As an initial
surgical intervention, the failure rate was approximately
30% [12]. Cheung et al. reported on 29 TEA reimplanta-
tions for bacterial PJI from 1976 to 2003. They showed a
Fig. 6 Left revision total elbow arthroplasty lateral view
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similar failure rate of 28%, with a 3-year survival of 77%
and 8-year survival of only 48% [16]. The necessity for
removal of all original hardware may be attributable to the
ability of fungi, including Aspergillus spp., to form hardy bio-
films overlying prostheses [17]. A 1998 retrospective study
on PJI in TEA showed that four of four Staphylococcus
epidermidis PJIs, a known biofilm-forming species,
failed irrigation and debridement with hardware re-
tention, compared to two of eight failures for
Staphylococcus aureus PJIs [18].
Conclusions
Fungal PJIs in TEA are different from both bacterial PJIs
in TEA, and fungal PJIs in hip and knee arthroplasty. Host
risk factors including inflammatory disease and immuno-
suppressive drugs combined with the subcutaneous anat-
omy of the elbow are possible risk factors that could
contribute to the higher complication and infection rates.
It has been hypothesized that the introduction of mod-
ern antirheumatic drugs has contributed to a decrease in
the utilization of joint surgery in rheumatoid arthritis
[17]. Even though improved medical treatment in RA
may have contributed to a decreased incidence of
rheumatoid elbow as an indication for TEA [6], patients
who do undergo the procedure for this indication may
be at higher risk of atypical PJIs caused by fungi.
A lack of literature on this rare but morbid complication
left the responsible team without a precedent on which to
base treatment. In this case, fungal infection of a TEA for
rheumatoid elbow proved to be an extremely difficult
complication to manage and caused considerable morbid-
ity to the patient. Owing to the rarity of this complication,
demonstrated by the lack of literature, future cases will
pose similar therapeutic dilemmas. If presented with a
similar case, the authors advise orthopedic surgeons and
infectious disease specialists not to attribute positive fun-
gal cultures to contamination, especially when it may
delay treatment in an immunocompromised host. As was
seen in this case, fungal infection may persist despite evi-
dence of preoperative sterility. In patients with a history of
recurrent infected TEA, surgeons should be wary of the
morbidity of multiple attempts at revision endoprosthetic
reconstruction in favor of earlier resection arthroplasty. It
is our hope that continued follow-up and future reports
will provide insight into a successful strategy for treatment
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